CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Cholesterol-Lowering Agents Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI PCI and CABG for Treating Stable Coronary Artery Disease Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory The Year in Cardiovascular Medicine 2020: Coronary Intervention Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Review Article2019 Feb;124(3):364-385.

JOURNAL:Circ Res. Article Link

Cholesterol-Lowering Agents

Rosenson RS, Hegele RA, Koenig W. Keywords: cardiovascular disease; cholesterol; myocardial infarction; patients; subtilisin

FULL TEXT PDF